Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. PRY:IM
5. PRYMY
6. SKA-B
7. PBA
8. CCH:LN
9. META
10. CCHGY

Go back to Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment
(NASDAQ: ABVX) Delayed: 144.65 +12.09 (9.12%)
Previous Close $132.56    52 Week High $ 
Open $138.87    52 Week Low $ 
Day High $146.68    P/E N/A 
Day Low $137.63    EPS $ 
Volume 4,020,767       

(NASDAQ: ABVX) Delayed: 144.65 +12.09 (9.12%)
Previous Close $132.56    52 Week High $ 
Open $138.87    52 Week Low $ 
Day High $146.68    P/E N/A 
Day Low $137.63    EPS $ 
Volume 4,020,767